115 related articles for article (PubMed ID: 35822421)
1. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary Thyroid Cancer.
Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
[TBL] [Abstract][Full Text] [Related]
2. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
3. Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.
Haque W; Verma V; Butler EB; Teh BS
Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30052835
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma.
Torabi SJ; Benchetrit L; Kuo Yu P; Cheraghlou S; Savoca EL; Tate JP; Judson BL
JAMA Otolaryngol Head Neck Surg; 2019 Aug; 145(8):708-715. PubMed ID: 31194229
[TBL] [Abstract][Full Text] [Related]
5. Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Culligan MJ; Friedberg JS; Simone CB
Lung Cancer; 2018 Jun; 120():7-13. PubMed ID: 29748018
[TBL] [Abstract][Full Text] [Related]
6. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
Bollig CA; Zitsch RP
Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
[TBL] [Abstract][Full Text] [Related]
7. Margin Positivity and Survival Outcomes: A Review of 14,471 Patients with 1-cm to 4-cm Papillary Thyroid Carcinoma.
Khan ZF; Kutlu O; Picado O; Lew JI
J Am Coll Surg; 2021 Apr; 232(4):545-550. PubMed ID: 33421566
[TBL] [Abstract][Full Text] [Related]
8. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
9. Impact of facility type and volume in low-grade glioma outcomes.
Zhu P; Du XL; Blanco AI; Ballester LY; Tandon N; Berger MS; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Sep; ():1-11. PubMed ID: 31561219
[TBL] [Abstract][Full Text] [Related]
10. Facility Volume and Survival in Nasopharyngeal Carcinoma.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Lee NY; Ho AS; Zumsteg ZS
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):408-417. PubMed ID: 29100787
[TBL] [Abstract][Full Text] [Related]
11. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
Zhu P; Du XL; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
[TBL] [Abstract][Full Text] [Related]
12. The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
Goshtasbi K; Abiri A; Lehrich BM; Haidar YM; Tjoa T; Kuan EC
Head Neck; 2021 Sep; 43(9):2755-2763. PubMed ID: 33998094
[TBL] [Abstract][Full Text] [Related]
13. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
[TBL] [Abstract][Full Text] [Related]
15. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
18. Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer.
Youngwirth LM; Adam MA; Scheri RP; Roman SA; Sosa JA
Ann Surg Oncol; 2016 Feb; 23(2):403-9. PubMed ID: 26416710
[TBL] [Abstract][Full Text] [Related]
19. The optimal surgical approach for papillary thyroid carcinoma with pathological n1 metastases: An analysis from the SEER database.
Ji T; Chen J; Mou J; Ni X; Guo Y; Zhang J; Wang S; Wang W; Zhang X; Tai J
Laryngoscope; 2020 Jan; 130(1):269-273. PubMed ID: 30953386
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
Yang GQ; Mhaskar R; Rishi A; Naghavi AO; Frakes JM; Almhanna K; Fontaine J; Pimiento JM; Hoffe SE
Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30597022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
